Comparison of PTPRR expression by Affymetrix Array of 14 samples reported a 3.381 fold reduction in prostate cancer relative to normal tissue [23], and a 4.686 fold reduction in metastatic versus primary prostate cancer [24] (Figure 4B). This evidence concerns the gene PTPRR and Familial prostate cancer.